New FDA approvals: how to use them, when to suggest them. New FDA approvals: how to use them, when to suggest them. RN Rodman MJ. PMID: 1546269 RN. 1992 Mar;55(3):58-65. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Rodman MJ. New FDA approvals: how to use them, when to suggest them. RN. 1992;55(3):58-65 APA Rodman, M. J. (1992). New FDA approvals: how to use them, when to suggest them. RN, 55(3), 58-65. MLA Rodman, M J. "New FDA approvals: how to use them, when to suggest them." RN vol. 55,3 (1992): 58-65. NLM Rodman MJ. New FDA approvals: how to use them, when to suggest them. RN. 1992 Mar;55(3):58-65. PMID: 1546269. Copy Download .nbib Format: NLM AMA APA MLA NLM
FDA problems with medications in the marketplace: II. FDA problems with medications in the marketplace: II. Hospital formulary Archambault GF. PMID: 1026690 Hosp Formul. 1976 May;11(5):272. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Archambault GF. FDA problems with medications in the marketplace: II. Hosp Formul. 1976;11(5):272 APA Archambault, G. F. (1976). FDA problems with medications in the marketplace: II. Hospital formulary, 11(5), 272. MLA Archambault, G F. "FDA problems with medications in the marketplace: II." Hospital formulary vol. 11,5 (1976): 272. NLM Archambault GF. FDA problems with medications in the marketplace: II. Hosp Formul. 1976 May;11(5):272. PMID: 1026690. Copy Download .nbib Format: NLM AMA APA MLA NLM
The expansion of drug certification by the FDA. The expansion of drug certification by the FDA. American journal of pharmacy and the sciences supporting public health TICE LF. PMID: 13776815 Am J Pharm Sci Support Public Health. 1960 Dec;132:431-2. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA TICE LF. The expansion of drug certification by the FDA. Am J Pharm Sci Support Public Health. 1960;132:431-2 APA TICE, L. F. (1960). The expansion of drug certification by the FDA. American journal of pharmacy and the sciences supporting public health, 132431-2. MLA TICE, L F. "The expansion of drug certification by the FDA." American journal of pharmacy and the sciences supporting public health vol. 132 (1960): 431-2. NLM TICE LF. The expansion of drug certification by the FDA. Am J Pharm Sci Support Public Health. 1960 Dec;132:431-2. PMID: 13776815. Copy Download .nbib Format: NLM AMA APA MLA NLM
FDA still faces questions on drug safety. FDA still faces questions on drug safety. Medicine & health (1997) [No authors listed] PMID: 17063621 Med Health. 2005 Mar;59(6):9-11. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA FDA still faces questions on drug safety. Med Health. 2005;59(6):9-11 APA (2005). FDA still faces questions on drug safety. Medicine & health (1997), 59(6), 9-11. MLA "FDA still faces questions on drug safety." Medicine & health (1997) vol. 59,6 (2005): 9-11. NLM FDA still faces questions on drug safety. Med Health. 2005 Mar;59(6):9-11. PMID: 17063621. Copy Download .nbib Format: NLM AMA APA MLA NLM
FDA decision making. FDA decision making. Health affairs (Project Hope) Pitts P. PMID: 15160828 Health Aff (Millwood). 2004 May-Jun;23(3):287; author reply 287-8. doi: 10.1377/hlthaff.23.3.287. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Pitts P. FDA decision making. Health Aff (Millwood). 2004;23(3):287; author reply 287-8doi: 10.1377/hlthaff.23.3.287. APA Pitts, P. (2004). FDA decision making. Health affairs (Project Hope), 23(3), 287; author reply 287-8. https://doi.org/10.1377/hlthaff.23.3.287 MLA Pitts, Peter. "FDA decision making." Health affairs (Project Hope) vol. 23,3 (2004): 287; author reply 287-8. doi: https://doi.org/10.1377/hlthaff.23.3.287 NLM Pitts P. FDA decision making. Health Aff (Millwood). 2004 May-Jun;23(3):287; author reply 287-8. doi: 10.1377/hlthaff.23.3.287. PMID: 15160828. Copy Download .nbib Format: NLM AMA APA MLA NLM
FDA says 'Look at the facts' when judging its record on drug approvals. FDA says 'Look at the facts' when judging its record on drug approvals. Formulary (Cleveland, Ohio) Gatty B. PMID: 10151732 Formulary. 1995 Jul;30(7):412, 411. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Gatty B. FDA says 'Look at the facts' when judging its record on drug approvals. Formulary. 1995;30(7):412, 411 APA Gatty, B. (1995). FDA says 'Look at the facts' when judging its record on drug approvals. Formulary (Cleveland, Ohio), 30(7), 412, 411. MLA Gatty, B. "FDA says 'Look at the facts' when judging its record on drug approvals." Formulary (Cleveland, Ohio) vol. 30,7 (1995): 412, 411. NLM Gatty B. FDA says 'Look at the facts' when judging its record on drug approvals. Formulary. 1995 Jul;30(7):412, 411. PMID: 10151732. Copy Download .nbib Format: NLM AMA APA MLA NLM
2017 FDA drug approvals. 2017 FDA drug approvals. Nature reviews. Drug discovery Mullard A. PMID: 29348678 Nat Rev Drug Discov. 2018 Feb;17(2):81-85. doi: 10.1038/nrd.2018.4. Epub 2018 Jan 19. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Mullard A. 2017 FDA drug approvals. Nat Rev Drug Discov. 2018;17(2):81-85doi: 10.1038/nrd.2018.4. APA Mullard, A. (2018). 2017 FDA drug approvals. Nature reviews. Drug discovery, 17(2), 81-85. https://doi.org/10.1038/nrd.2018.4 MLA Mullard, Asher. "2017 FDA drug approvals." Nature reviews. Drug discovery vol. 17,2 (2018): 81-85. doi: https://doi.org/10.1038/nrd.2018.4 NLM Mullard A. 2017 FDA drug approvals. Nat Rev Drug Discov. 2018 Feb;17(2):81-85. doi: 10.1038/nrd.2018.4. Epub 2018 Jan 19. PMID: 29348678. Copy Download .nbib Format: NLM AMA APA MLA NLM
2021 FDA approvals. 2021 FDA approvals. Nature reviews. Drug discovery Mullard A. PMID: 34983958 Nat Rev Drug Discov. 2022 Jan 04; doi: 10.1038/d41573-022-00001-9. Epub 2022 Jan 04. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Mullard A. 2021 FDA approvals. Nat Rev Drug Discov. 2022;doi: 10.1038/d41573-022-00001-9. APA Mullard, A. (2022). 2021 FDA approvals. Nature reviews. Drug discovery, . https://doi.org/10.1038/d41573-022-00001-9 MLA Mullard, Asher. "2021 FDA approvals." Nature reviews. Drug discovery vol. (2022). doi: https://doi.org/10.1038/d41573-022-00001-9 NLM Mullard A. 2021 FDA approvals. Nat Rev Drug Discov. 2022 Jan 04; doi: 10.1038/d41573-022-00001-9. Epub 2022 Jan 04. PMID: 34983958. Copy Download .nbib Format: NLM AMA APA MLA NLM
Red tape hampers FDA as illegal prescription-drug importation booms. Red tape hampers FDA as illegal prescription-drug importation booms. Medicine & health (1997) [No authors listed] PMID: 16320970 Med Health. 2005 Nov 21;59(42):1, 6. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Red tape hampers FDA as illegal prescription-drug importation booms. Med Health. 2005;59(42):1, 6 APA (2005). Red tape hampers FDA as illegal prescription-drug importation booms. Medicine & health (1997), 59(42), 1, 6. MLA "Red tape hampers FDA as illegal prescription-drug importation booms." Medicine & health (1997) vol. 59,42 (2005): 1, 6. NLM Red tape hampers FDA as illegal prescription-drug importation booms. Med Health. 2005 Nov 21;59(42):1, 6. PMID: 16320970. Copy Download .nbib Format: NLM AMA APA MLA NLM
FDA approvals for the first 6 months of 2017. FDA approvals for the first 6 months of 2017. Nature reviews. Drug discovery Mullard A. PMID: 28757628 Nat Rev Drug Discov. 2017 Jul 31;16(8):519. doi: 10.1038/nrd.2017.148. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Mullard A. FDA approvals for the first 6 months of 2017. Nat Rev Drug Discov. 2017;16(8):519doi: 10.1038/nrd.2017.148. APA Mullard, A. (2017). FDA approvals for the first 6 months of 2017. Nature reviews. Drug discovery, 16(8), 519. https://doi.org/10.1038/nrd.2017.148 MLA Mullard, Asher. "FDA approvals for the first 6 months of 2017." Nature reviews. Drug discovery vol. 16,8 (2017): 519. doi: https://doi.org/10.1038/nrd.2017.148 NLM Mullard A. FDA approvals for the first 6 months of 2017. Nat Rev Drug Discov. 2017 Jul 31;16(8):519. doi: 10.1038/nrd.2017.148. PMID: 28757628. Copy Download .nbib Format: NLM AMA APA MLA NLM
The FDA and Adulterated Supplements-Dereliction of Duty. The FDA and Adulterated Supplements-Dereliction of Duty. JAMA network open Cohen PA. PMID: 30646231 JAMA Netw Open. 2018 Oct 05;1(6):e183329. doi: 10.1001/jamanetworkopen.2018.3329. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Cohen PA. The FDA and Adulterated Supplements-Dereliction of Duty. JAMA Netw Open. 2018;1(6):e183329doi: 10.1001/jamanetworkopen.2018.3329. APA Cohen, P. A. (2018). The FDA and Adulterated Supplements-Dereliction of Duty. JAMA network open, 1(6), e183329. https://doi.org/10.1001/jamanetworkopen.2018.3329 MLA Cohen, Pieter A. "The FDA and Adulterated Supplements-Dereliction of Duty." JAMA network open vol. 1,6 (2018): e183329. doi: https://doi.org/10.1001/jamanetworkopen.2018.3329 NLM Cohen PA. The FDA and Adulterated Supplements-Dereliction of Duty. JAMA Netw Open. 2018 Oct 05;1(6):e183329. doi: 10.1001/jamanetworkopen.2018.3329. PMID: 30646231. Copy Download .nbib Format: NLM AMA APA MLA NLM
FDA approvals 'paralyzed'--Dingell. FDA approvals 'paralyzed'--Dingell. Modern healthcare Wagner M. PMID: 10120377 Mod Healthc. 1992 Sep 14;22(37):68. No abstract available. Share Share on social media Direct link Direct link Cite Cite AMA Wagner M. FDA approvals 'paralyzed'--Dingell. Mod Healthc. 1992;22(37):68 APA Wagner, M. (1992). FDA approvals 'paralyzed'--Dingell. Modern healthcare, 22(37), 68. MLA Wagner, M. "FDA approvals 'paralyzed'--Dingell." Modern healthcare vol. 22,37 (1992): 68. NLM Wagner M. FDA approvals 'paralyzed'--Dingell. Mod Healthc. 1992 Sep 14;22(37):68. PMID: 10120377. Copy Download .nbib Format: NLM AMA APA MLA NLM
